Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025
Dana-Farber Cancer Institute’s groundbreaking research continues to shape the landscape of oncology as their experts present a series of pivotal ...
Tag: Phase 3 clinical trials
New Clinical Trials Confirm That Increased Semaglutide Dosages Safely Boost Weight Loss and Health Benefits in Adults with Obesity
In a groundbreaking development for the treatment of obesity, recent phase 3 clinical trials have demonstrated that a significantly higher ...
Moffitt to Unveil Plenary and Late-Breaking Findings on Blood, Melanoma, and Brain Metastases at ASCO 2025
TAMPA, Fla. – The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, set to convene from May 30 to ...
City of Hope Researchers Showcase Cutting-Edge Discoveries at AACR Annual Meeting
In a groundbreaking showcase at the AACR Annual Meeting 2025, the renowned City of Hope cancer research and treatment center ...
Dana-Farber Researchers to Showcase Pivotal Transplant and Cellular Therapy Findings at 2025 Tandem Meetings
As the world’s foremost gathering in hematopoietic cell transplantation (HCT) and cellular therapy, the 2025 Tandem Meetings promises to be ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!